Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Ascendis Pharma A/S

216.32
-1.7800-0.82%
Post-market: 216.320.00000.00%16:10 EST
Volume:693.06K
Turnover:150.45M
Market Cap:13.35B
PE:-47.66
High:221.80
Open:217.85
Low:213.02
Close:218.10
52wk High:242.00
52wk Low:124.06
Shares:61.70M
Float Shares:60.08M
Volume Ratio:0.68
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5384
EPS(LYR):-6.7615
ROE:-818.43%
ROA:-7.69%
PB:-64.59
PE(LYR):-31.99

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
Ascendis Pharma A/S
Exchange:
NASDAQ
Establishment Date:
2006
Employees:
1017
Office Location:
Tuborg Boulevard 12,Hellerup,Capital Region of Denmark,Denmark
Website:
http://www.ascendispharma.com
Zip Code:
2900
Phone:
45 70 22 22 44
Fax:
- -
Introduction:
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company also develops TransCon Growth Hormone for treating pediatric GHD, adult GHD, and turner syndrome; TransCon Parathyroid Hormone for adult patients with hypoparathyroidism; and TransCon C-type natriuretic peptide for achondroplasia. In addition, it is developing TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/? for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Directors

Name
Position
Albert Cha
Chairman of the Board and Director
Jan Moller Mikkelsen
Chief Executive Officer and Director and President
Lars Holtug
Director
Lisa Bright
Director
Siham Imani
Director
William Carl Fairey Jr.
Director

Shareholders

Name
Position
Jan Moller Mikkelsen
Chief Executive Officer and Director and President
Mads Bodenhoff
Head of Finance and Principal Accounting Officer and Senior Vice President
Scott T. Smith
Executive Vice President, Chief Financial Officer
Aimee Shu
Executive Vice President, Chief Medical Officer
Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Jay Donovan Wu
Executive Vice President, U.S. President
Jethro Ekuta
Chief Regulatory & Safety Officer
Kennett Sprogøe
Executive Vice President, Head of Innovation and Research
Lotte Sonderbjerg
Executive Vice President, Chief Administrative Officer
Michael Wolff Jensen
Executive Vice President, Chief Legal Officer
Sherrie Glass
Chief Business Officer
Stina Singel
Executive Vice President, Head of Clinical Development, Oncology